Zobrazeno 1 - 10
of 396
pro vyhledávání: '"third dose"'
Publikováno v:
Mathematical Biosciences and Engineering, Vol 21, Iss 8, Pp 6807-6828 (2024)
The COVID-19 pandemic continues to pose significant challenges to global public health, necessitating the development of effective vaccination strategies to mitigate disease transmission. In Thailand, the COVID-19 epidemic has undergone multiple wave
Externí odkaz:
https://doaj.org/article/25da02c6eced45e0a2c46e16befcee82
Autor:
Hyeon Hwa Kim, Hye Kyung Lee, Lothar Hennighausen, Priscilla A. Furth, Heungsup Sung, Jin Won Huh
Publikováno v:
Vaccine: X, Vol 20, Iss , Pp 100565- (2024)
The widespread administration of an additional dose of the SARS-CoV-2 vaccine has been promoted across adult populations, demonstrating a robust immune response against COVID-19. Longitudinal studies provide crucial data on the durability of immune r
Externí odkaz:
https://doaj.org/article/176f010e6b804221b7174459c8b0aafd
Publikováno v:
Jurnal Berkala Epidemiologi, Vol 12, Iss 2, Pp 192-202 (2024)
Background: Booster vaccinations are a way to keep the body protected against COVID-19. Mojolangu Health Center is one of the densely populated areas which is part of the Lowokwaru sub-district and borders the Belimbing sub-district; the two sub-dist
Externí odkaz:
https://doaj.org/article/2f53a8053db24c62beddc8210651bf0c
Autor:
Becky Mingyao Ma, Anthony Raymond Tam, Kam Wa Chan, Ivan Fan Ngai Hung, Sydney Chi Wai Tang, Tak Mao Chan, Desmond Yat-Hin Yap
Publikováno v:
Kidney Diseases, Pp 1-11 (2024)
Background: A three-dose regimen is the current standard for COVID-19 vaccination, but systematic data on immunogenicity and safety in chronic kidney disease patients remains limited. Objectives: We conducted a meta-analysis on the immunogenicity and
Externí odkaz:
https://doaj.org/article/81c043359975443db80075818c564c40
Autor:
Blanka Wolszczak-Biedrzycka, Anna Bieńkowska, Beata Cieślikiewicz, Elwira Smolińska-Fijołek, Grzegorz Biedrzycki, Justyna Dorf
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 722-732 (2023)
AbstractAim A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease in anti-SARS-CoV-2S antibody levels over time, new mutations, and low global vaccination rates. In this study, anti-SARS-CoV-2S antibody l
Externí odkaz:
https://doaj.org/article/6af4a9d187cf4f14b9e29be0b5f58ceb
Autor:
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Julio Rodrigo Giron Berrios, Eleonora Marrucci, Cristina Fiore, Marta Schirripa, Carlo Signorelli, Mario Giovanni Chilelli, Francesca Primi, Gloria Pessina, Federica Natoni, Maria Assunta Silvestri, Enzo Maria Ruggeri
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 5103-5115 (2023)
(1) Background: The clinical implications of COVID-19 outbreaks following SARS-CoV-2 vaccination in immunocompromised recipients are a worldwide concern. Cancer patients on active treatment remain at an increased risk of developing breakthrough infec
Externí odkaz:
https://doaj.org/article/99101d499d93422bac199df094e1c46f
Autor:
Fabrizio Nelli, Agnese Fabbri, Andrea Botticelli, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Simone Scagnoli, Simona Pisegna, Alessio Cirillo, Valentina Panichi, Annalisa Massari, Maria Assunta Silvestri, Enzo Maria Ruggeri
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeMetastatic breast cancer patients are the most prevalent oncology population with advanced disease facing COVID-19 pandemic. Immune responses after mRNA-based vaccination during treatment with CDK4/6 inhibitors or HER2-directed agents remain u
Externí odkaz:
https://doaj.org/article/cf6cd96220074f03b7cad657746c5eb3
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 347-354 (2023)
Objectives: To investigate the role of immunogenicity after the third vaccine dose against Omicron infection and COVID-19-compatible symptoms of infection. Methods: First, we examined vaccine effectiveness (VE) of the third dose against the second do
Externí odkaz:
https://doaj.org/article/fec3573d884a494d9dd25717a6e815d2
Publikováno v:
Vaccines, Vol 12, Iss 3, p 244 (2024)
Objective: This study investigates the effectiveness of the 1st booster dose against COVID-19 severe and critical hospitalizations and deaths occurring due to the Omicron wave in Morocco. Participants/methods: This study uses nationally representativ
Externí odkaz:
https://doaj.org/article/2fbebfcee4b040e79fa451f4bee67be4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.